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ABSTRACT BODY: 
Abstract Body:  Background
High adherence to maintenance inhaled therapies is associated with better outcomes but adherence levels are
generally low and there is currently no systematic adherence intervention for people with CF.
The Sheffield Adult CF centre has run pilot projects to improve nebuliser adherence since 2013, leading to a 2014
NIHR programme grant to develop a systematic adherence intervention. We hypothesised that the pilot projects would
have improved the adherence levels among adults receiving care at our centre.
 
Aims
To determine the overall change in objective nebuliser adherence and health outcomes in our centre from 2013-2016
 
Methods
This is a retrospective analysis of routinely collected clinical data. Adults on ivacaftor or with previous lung
transplantation were excluded.
Demographic data, spirometry, BMI, intravenous antibiotics days and prescription details were obtained by reviewing
patient notes and electronic patient records. Adherence data were captured with I-neb nebuliser, calculated as
normative adherence[1] and clustered according to the methods we have described.[2] Data from 2013-2016 were
compared using Friedman (continuous data) or Cochran's Q (binary data) test.
 
Results
Despite the increasing age of the cohort, FEV1 and IV use remained relatively stable. There was a consistent
reduction in the rate of FEV1 decline from 2013-2014 (median 椴2%, IQR -6 to -1%) to 2015-2016 (median 0%, IQR -3
to 2%), p=0.012. BMI had also increased consistently.
The proportion of I-neb users remained stable. Median normative adherence to maintenance inhaled therapies
increased from 32.8% in 2013 to 45.6% in 2016, p=0.004.
Adherence clusters consider both magnitude and variation in adherence. The proportion of adults with adherence
cluster 3 ('moderate') or 4 ('high') increased from 22/89 (24.7%) in 2013 to 39/102 (38.2%) in 2016, p=0.010. Those
with adherence cluster 3 or 4 have less FEV1 decline (median 0.0% vs 椴1.0% for 2015-2016) and less IV use (median
14 days vs 26 days for 2015).
 
Conclusions
There were sustained improvements in objective adherence and health outcomes although a systematic adherence
intervention is still being iterated. Adherence remains a challenging issue but these results should engender hope
within the CF community that medication adherence can be improved.
Adults with 'moderate' or 'high' adherence have better health outcomes compared to those with lower adherence.
 
References
1. Hoo ZH, et al. Patient Prefer Adherence 2016;10:887-900
2. Hoo ZH, et al. Patient Prefer Adherence 2017;11:631-42
TABLE: 





































































14 (0 - 35) 14 (0 - 28) 14 (0 - 35) 14 (0 - 40) 0.001 ○
(IQR)
○ = Friedman test;
⌒ = Cochran's Q test
(No Image Selected)
